Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot PK/PD study of prasugrel versus ticagrelor during PCI for acute myocardial infarction
2014-004238-25Phase 4Completed
- Sponsor
- The Royal Wolverhampton NHS Trust
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prasugrel and ticagrelor in myocardial infarction (MI) and acute coronary syndrome (ACS) (2 arms), sponsored by The Royal Wolverhampton NHS Trust. Primary endpoint: Degree of platelet inhibition over 4 hours. Started Jan 2015; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2014-004238-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004238-25.